Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
Could Serum Neurofilament Light (sNFL) Chain Level Help Guide MS Management?
April 2024 Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month Serum…
Stuart Schlossman
Factors Influencing Time Delays in Initiating High-Efficacy Treatment in Multiple Sclerosis: Valentin Krüger, MD
September 19, 2024 By Valentin Krüger, MD / Isabella Ciccone, MPH — Fact checked by Marco Meglio The neurology resident at the…
Stuart Schlossman
Best Practices Guideline on the Use of Neurofilament
Consortium of Multiple Sclerosis Centers (CMSC) Best Practices Guideline on the Use of Neurofilament Biomarkers in MS Erratum: This document…
Stuart Schlossman
Multiple Sclerosis: Can a Blood Test Detect MS Years Before Symptoms Appear? New Research Encouraging
Written By: John Fernandez Published: May 1, 2024 Disponible en Español New clinical trial findings could advance the early treatment for patients…
Stuart Schlossman
The MS Views and News Learning Channel, Presents: THE 2023 MS SYMPOSIUM – watch these educational videos with MS Neurologists Boster, Rosenthal, Steingo and more
PLAYING 2023 MS Symposium (Part 1 of 5) – LIVING WELL with MS, Pain Management, Biomarkers and More 40:26…
Stuart Schlossman
Neurofilament Light Chain Assay
Advance your neurology research from discovery to diagnostics by reliably measuring neurofilament light (NfL). The Quanterix Simoa® NfL Assay is…
Stuart Schlossman
video: Biomarkers and Biosimilars for MS — an MS Views NOW event
https://bit.ly/3SOafcO Stay informed with MS information, news and resources. Sign-up Here: https://bit.ly/3NkMIeR Visit the MS Views and News articles and videos…
Stuart Schlossman
Neurofilament Light Predicts MS Worsening in Silent Progression
NfL changes occurred in advance of, not coincident with, clinical worsening by Judy George, Deputy Managing Editor, MedPage Today October 17,…
Stuart Schlossman
Barriers in MS Treatment Adherence
2023 , Octave Although there currently is no cure for multiple sclerosis, in recent decades, 20+ disease-modifying therapies (DMTs)…
Stuart Schlossman
